基本データ
- 【業種】
- 医薬品
- 【市場】
- プライム（内国株式）
- 【決算期】
- 3月
- 【会社設立】
- 【上場】
- 1949.5
- 【直近決算日】
- 2025-04-25（4Q）
- 【決算予定日】
- 未定
- 【時価総額】
- 2兆5181億円
- 【PBR】
- 1.82倍
- 【配当利回り(予)】
- 5.61%
企業概要
当社グループは、医薬品の研究開発、製造、販売を主な事業とし、合計77社の連結子会社と6社の持分法適用会社から構成される。
事業は単一の医薬品事業に特化し、米国、アイルランド、中国、ヨーロッパ各地域における研究開発機能や製造、販売機能を持つ関係会社によって支えられている。
主力製品には前立腺がん治療薬「イクスタンジ」や尿路上皮がん治療剤「パドセブ」、免疫抑制剤「プログラフ」などが含まれ、特にアンメットメディカルニーズの高い疾患領域において、革新的な新薬の開発に注力している。
事業は単一の医薬品事業に特化し、米国、アイルランド、中国、ヨーロッパ各地域における研究開発機能や製造、販売機能を持つ関係会社によって支えられている。
主力製品には前立腺がん治療薬「イクスタンジ」や尿路上皮がん治療剤「パドセブ」、免疫抑制剤「プログラフ」などが含まれ、特にアンメットメディカルニーズの高い疾患領域において、革新的な新薬の開発に注力している。
業績修正履歴
| 年度 | タイプ | 日付 | 売上高 | 営業利益 | 経常利益 | 純利益 |
|---|---|---|---|---|---|---|
| 2023-03 | 新規 | 2022-04-27 | 1,443,000 | 269,000 | 267,000 | 208,000 |
| 変更 | 2022-10-31 | 1,529,000(⬆) | 269,000(→) | 267,000(→) | 208,000(→) | |
| 変更 | 2023-02-06 | 1,529,000(→) | 195,000(⬇) | 193,000(⬇) | 150,000(⬇) | |
| 変更 | 2023-04-11 | 1,529,000(→) | 137,000(⬇) | 135,000(⬇) | 105,000(⬇) | |
| 2024-03 | 新規 | 2023-04-27 | 1,520,000 | 288,000 | 289,000 | 227,000 |
| 変更 | 2023-08-01 | 1,520,000(→) | 259,000(⬇) | 260,000(⬇) | 204,000(⬇) | |
| 変更 | 2023-11-01 | 1,608,000(⬆) | 123,000(⬇) | 121,000(⬇) | 85,000(⬇) | |
| 変更 | 2024-02-05 | 1,562,000(⬇) | 83,000(⬇) | 82,000(⬇) | 58,000(⬇) | |
| 変更 | 2024-04-12 | 1,562,000(→) | 13,000(⬇) | 12,000(⬇) | 3,000(⬇) | |
| 2025-03 | 新規 | 2024-04-25 | 1,650,000 | 48,000 | 43,000 | 30,000 |
| 変更 | 2024-10-30 | 1,800,000(⬆) | 80,000(⬆) | 70,000(⬆) | 50,000(⬆) | |
| 変更 | 2025-01-24 | 1,900,000(⬆) | 11,000(⬇) | 1,000(⬇) | 14,000(⬇) | |
| 今期 | 新規 | 2025-04-25 | 1,930,000 | 160,000 | 150,000 | 130,000 |
売上高
経常利益
純利益
| 決算期 | 四半期 | 売上高 | 営業利益 | 経常利益 | 純利益 | 1株当たり純利益 | 営業利益率 | 経常利益率 | 売上高/前年比 | 営業利益/前年比 | 経常利益/前年比 | 純利益/前年比 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 予想 | 1,930,000 | 160,000 | 150,000 | 130,000 | 72.61 | 8.29% | 7.77% | 0.92% | 289.87% | 380.20% | 156.17% | |
| 2025-03 | 4 | 1,912,323 | 41,039 | 31,237 | 50,747 | 28.35 | 2.15% | 1.63% | 19.2% | 60.8% | 25.1% | 197.7% |
| 3 | 1,453,029 | -22,481 | -29,317 | -24,149 | -13.49 | -1.55% | -2.02% | 22.2% | ― | ― | ― | |
| 2 | 935,621 | 93,710 | 89,042 | 73,511 | 41.06 | 10.02% | 9.52% | 22% | 69.9% | 58.1% | 105.3% | |
| 1 | 473,124 | 50,657 | 50,495 | 37,603 | 21 | 10.71% | 10.67% | 26.2% | 10.6% | 7.8% | 13.5% | |
| 2024-03 | 4 | 1,603,672 | 25,518 | 24,969 | 17,045 | 9.51 | 1.59% | 1.56% | 5.6% | -80.8% | -81.1% | -82.7% |
| 3 | 1,189,070 | 74,119 | 73,630 | 50,323 | 28.06 | 6.23% | 6.19% | 2.1% | -59.1% | -59.1% | -65.3% | |
| 2 | 767,138 | 51,016 | 52,178 | 31,670 | 17.66 | 6.65% | 6.8% | 0.6% | -57.4% | -56.7% | -67.2% | |
| 1 | 374,990 | 45,794 | 46,850 | 33,129 | 18.46 | 12.21% | 12.49% | -1.8% | 38.2% | 47.9% | 33.5% | |
| 2023-03 | 4 | 1,518,619 | 133,029 | 132,361 | 98,714 | 54.24 | 8.76% | 8.72% | 17.2% | -14.6% | -15.6% | -20.4% |
| 3 | 1,164,365 | 181,279 | 180,238 | 144,839 | 79.43 | 15.57% | 15.48% | 17.3% | 7% | 7.7% | 9.3% | |
| 2 | 762,185 | 119,891 | 120,480 | 96,434 | 52.87 | 15.73% | 15.81% | 17% | 33% | 35.2% | 34.7% | |
| 1 | 381,791 | 33,147 | 31,679 | 24,812 | 13.59 | 8.68% | 8.3% | 17.1% | -8.2% | -11.6% | -19.1% | |
| 2022-03 | 4 | 1,296,163 | 155,686 | 156,886 | 124,086 | 67.08 | 12.01% | 12.1% | 3.7% | 14.4% | 8% | 2.9% |
| 3 | 992,293 | 169,371 | 167,402 | 132,495 | 71.51 | 17.07% | 16.87% | 5.5% | 6.2% | 1.9% | -0.3% | |
| 2 | 651,666 | 90,169 | 89,085 | 71,609 | 38.65 | 13.84% | 13.67% | 5.9% | 3.8% | 0% | -1.7% | |
| 1 | 326,143 | 36,090 | 35,830 | 30,687 | 16.56 | 11.07% | 10.99% | 6.2% | -40.7% | -40.5% | -39.1% | |
| 2021-03 | 4 | 1,249,528 | 136,051 | 145,324 | 120,589 | 64.93 | 10.89% | 11.63% | -3.9% | -44.2% | -40.8% | -38.3% |
| 3 | 940,907 | 159,470 | 164,227 | 132,917 | 71.56 | 16.95% | 17.45% | -4.8% | -32.9% | -31.3% | -30.1% | |
| 2 | 615,480 | 86,872 | 89,091 | 72,838 | 39.21 | 14.11% | 14.48% | -5.4% | -46.4% | -44.9% | -43.3% | |
| 1 | 306,969 | 60,815 | 60,238 | 50,413 | 27.14 | 19.81% | 19.62% | -8.1% | -21.1% | -21.3% | -13.9% | |
| 2020-03 | 4 | 1,300,843 | 243,991 | 245,350 | 195,411 | 104.15 | 18.76% | 18.86% | -0.4% | 0% | -1.5% | -12.1% |
| 3 | 988,535 | 237,658 | 239,185 | 190,021 | 100.96 | 24.04% | 24.2% | -1.6% | 13.5% | 12.4% | -0.8% | |
| 2 | 650,470 | 162,196 | 161,584 | 128,527 | 68.16 | 24.94% | 24.84% | 0.5% | 27.9% | 25.9% | 23.7% | |
| 1 | 334,134 | 77,086 | 76,528 | 58,518 | 31.03 | 23.07% | 22.9% | 1.5% | 21.3% | 18.7% | 7.3% | |
| 2019-03 | 4 | 1,306,348 | 243,912 | 248,967 | 222,265 | 115.05 | 18.67% | 19.06% | 0.5% | 14.4% | 14.1% | 35% |
| 3 | 1,005,028 | 209,371 | 212,828 | 191,535 | 98.63 | 20.83% | 21.18% | 0.6% | 16.5% | 15.3% | 34.3% | |
| 2 | 647,096 | 126,842 | 128,298 | 103,867 | 53.2 | 19.6% | 19.83% | 1.1% | 32% | 26.7% | 26.5% | |
| 1 | 329,085 | 63,548 | 64,495 | 54,559 | 27.68 | 19.31% | 19.6% | 2% | 46% | 33.1% | 28.5% | |
| 2018-03 | 4 | 1,300,316 | 213,258 | 218,113 | 164,679 | 81.11 | 16.4% | 16.77% | -0.9% | -18.2% | -22.6% | -24.7% |
| 3 | 999,443 | 179,751 | 184,605 | 142,614 | 69.84 | 17.99% | 18.47% | -0.6% | -22.3% | -24.3% | -20.2% | |
| 2 | 639,754 | 96,077 | 101,224 | 82,117 | 39.97 | 15.02% | 15.82% | -1.8% | -38.8% | -35.8% | -28.6% | |
| 1 | 322,571 | 43,529 | 48,471 | 42,468 | 20.57 | 13.49% | 15.03% | -4.5% | -53.1% | -48% | -36.2% | |
| 2017-03 | 4 | 1,311,665 | 260,830 | 281,769 | 218,701 | 103.69 | 19.89% | 21.48% | -4.4% | 4.8% | 7.6% | 12.9% |
| 3 | 1,005,587 | 231,289 | 243,898 | 178,800 | 84.38 | 23% | 24.25% | -5.6% | 7.3% | 6.8% | 8.7% | |
| 2 | 651,673 | 157,057 | 157,772 | 115,064 | 54.16 | 24.1% | 24.21% | -5.2% | 18.4% | 8.5% | 11.8% | |
| 1 | 337,752 | 92,866 | 93,184 | 66,613 | 31.35 | 27.5% | 27.59% | -1.7% | 50% | 37.7% | 49.3% | |
| 2016-03 | 4 | 1,372,706 | 248,986 | 261,770 | 193,687 | 89.75 | 18.14% | 19.07% | 10.1% | 34.1% | 38% | 42.6% |
| 3 | 1,065,666 | 215,599 | 228,463 | 164,547 | 75.93 | 20.23% | 21.44% | 11.8% | 33.3% | 41.4% | 43.4% | |
| 2 | 687,501 | 132,637 | 145,418 | 102,933 | 47.3 | 19.29% | 21.15% | 15.7% | 28.5% | 41.6% | 47.1% | |
| 1 | 343,659 | 61,911 | 67,664 | 44,622 | 20.38 | 18.02% | 19.69% | 16.4% | 22.4% | 34.6% | 24.4% |